Merck and Siemens to Accelerate AI Driven Drug Development
Merck and Siemens have expanded their collaboration by signing a new Memorandum of Understanding (MoU) aimed at advancing digital transformation in the life science...
ABPI Launches Manifesto to Advance Scottish Pharma Sector
The Association of the British Pharmaceutical Industry (ABPI) has released its manifesto for the Scottish Government, calling for political leaders to act now and...
GSK to Invest $30B in Drug Manufacturing and R&D in the US
GSK plc has unveiled a plan to invest $30 billion into research, development and supply chain infrastructure across the United States. The announcement includes...
MGI Tech and JCBio Advance Multi-Omics with DCS Lab Project
MGI Tech Co., Ltd., a developer of advanced life sciences technologies, and JCBio Co., Ltd., a biotechnology company in South Korea, have entered into...
Novartis and Arrowhead Sign Deal to Advance Parkinson’s Drug
Novartis has renewed its focus on Parkinson’s disease through a significant collaboration with Arrowhead Pharmaceuticals, marking another strategic step into neuroscience drug development. The...
Roche’s Genentech Launches New Manufacturing Facility in USA
Genentech, part of the Roche Group, has broken ground on its latest US manufacturing facility in Holly Springs, North Carolina. The development represents the...
J&J Investment of $2B Boosts US Drug Manufacturing Capacity
Johnson & Johnson, an industry leader known for its global healthcare innovation, unveiled plans to increase its presence in the state of North Carolina...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...